Genetic testing

Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention

Volumn , Issue , 2008, Pages 444-458

  Tester, David J ^a   Ackerman, Michael J ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952721460     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-854-8_31     Document Type: Chapter

References (19)

1. Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: A population study. Am J Hum Genet 1988;42(5):677-693.
2. Strachan T, Read A. Human Molecular Genetics, 2nd ed. New York: Wiley-Liss, 1999.
3. Nussbaum RL, McInnes RR, Willard HF, Eds. Thompson and Thompson Genetics in Medicine, 6th ed. Philadelphia, PA: W. B. Saunders Co, 2001:51-94.
4. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2(5):507-517.
5. Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 2006;21(3):166-172.
6. Tester DJ, Cronk LB, Carr JL, et al. Allelic dropout in long QT syndrome genetic testing: A possible mechanism underlying false negative results. Heart Rhythm 2006;3(7):815-821.
7. Ning L, Moss A, Zareba W, et al. Denaturing highperformance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test 2003;7(3):249-253.
8. Spiegelman JI, Mindrinos MN, Oefner PJ. Highaccuracy DNA sequence variation screening by DHPLC. BioTechniques 2000;29(5):1084-1090, 1092.
9. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: Implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clinic Proc 2003;78(12):1479-1487.
10. Ackerman MJ, Splawski I, Makielski JC, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.[see comment]. Heart Rhythm 2004;1(5):600-607.
11. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80(5):795-803.
12. Wang Q, Shen J, Li Z, et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 1995;4(9):1603-1607.
13. Napolitano C, Bloise R, Priori SG. Gene-specific therapy for inherited arrhythmogenic diseases. Pharmacol Ther 2006;110(1):1-13.
14. Constantin CM, Faucett A, Lubin IM. A primer on genetic testing. J Midwifery Womens Health 2005;50(3):197-204.
15. Tester DJ, Ackerman MJ. Genetic testing for cardiac channelopathies: Ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm 2005;2(6):675-677.
16. Priori SG, Napolitano C. Role of genetic analyses in cardiology: Part I: Mendelian diseases: Cardiac channelopathies. Circulation 2006;113(8):1130-1135.
17. Thomas SM. Society and ethics-the genetics of disease. Curr Opin Genet Dev 2004;14(3):287-291.
18. Lea DH, Williams J, Donahue MP. Ethical issues in genetic testing. J Midwifery Womens Health 2005;50(3):234-240.
19. Van Riper M. Genetic testing and the family. J Midwifery Womens Health 2005;50(3):227-233.